Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Capabilities
Manufacturing Network
Plants & 20 workshops
Manufacturing Network
Research & Development
Labs, ATMP & formulation
Research & Development
Quality & GMP
Standards & traceability
Quality & GMP
Alliance Regenerative Centre
Stem-cell, NK & exosome science
Alliance Regenerative Centre
Integrated Value Chain
Farm → chemicals → finished
Integrated Value Chain
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
Explore capabilities
Product photo — to be added
Rx
Cancer & Blood Disorders

ALIMOBOTINIB

Mobocertinib
Generic (INN)
Mobocertinib
Strength
40mg
Packaging
120 capsules/bottle
Indication
Targeted treatment for EGFR exon 20 insertion non-small cell lung cancer. (See package insert.)
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in Cancer & Blood Disorders

View all →
ALIAXITINIB
ALIAXITINIB
Axitinib
ALILSAZOMI
ALILSAZOMI
Ixazomib citrate
ALIMACATEN
ALIMACATEN
Mavacamten
ALIQUZATINI 26.5mg
Quizartinib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文